Human papillomavirus type specific DNA and RNA persistence - Implications for cervical disease progression and monitoring

被引:123
作者
Cuschieri, KS [1 ]
Whitley, MJ [1 ]
Cubie, HA [1 ]
机构
[1] Royal Infirm, Specialist Virol Ctr, Edinburgh EH16 4SA, Midlothian, Scotland
关键词
HPV; genotyping; E6/E7 transcript detection; dyskaryosis;
D O I
10.1002/jmv.20062
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In 2000, we monitored the course and persistence of human papillomavirus (HPV) infection in 54 women who were HPV positive and free of any cytological disease using HPV-DNA genotyping with a linear array assay (baseline). The impact of HPV infection on development of cervical cytological abnormality (dyskaryosis) was monitored by repeat HPV genotyping and cytological assessment 2 years later. Detection of mRNA transcripts of known HPV oncogenes E6 and E7 using NASBA methodology and specific molecular beacons for five common HPV types was also performed at both time points. A total of 11/54 (20%) women developed dyskaryosis after 2 years with 31/54 and 23/54 women exhibiting transient and persistent infections respectively, as monitored by DNA genotyping. Women who maintained type-specific persistent HPV infection were significantly more likely to develop dyskaryosis compared to those who exhibited a transient infection (P=0.001). The presence of HPV mRNA E6/E7 transcripts was less sensitive but more specific for the detection of disease at follow up. Moreover, women who were DNA positive and also positive for mRNA transcripts at baseline were significantly more likely to harbour persistent infection compared to those in whom DNA only was detected at baseline (P=0.013). This study highlights the importance of detecting persistent type specific HPV infection to identify those women more at risk of developing cervical abnormalities, either by repeated DNA genotyping, or potentially by RNA based techniques that may be more predictive of persistent infection if per-formed at a single time point. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 18 条
[1]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[2]   Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples [J].
Coutlée, F ;
Gravitt, P ;
Kornegay, J ;
Hankins, C ;
Richardson, H ;
Lapointe, N ;
Voyer, H ;
Franco, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :902-907
[3]   Development of an automated extraction procedure for detection of human papillomavirus DNA in liquid based cytology samples [J].
Cuschieri, KS ;
Seagar, AL ;
Moore, C ;
Gilkison, G ;
Kornegay, J ;
Cubie, HA .
JOURNAL OF VIROLOGICAL METHODS, 2003, 107 (01) :107-113
[4]   THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937
[5]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[6]   NASBA ISOTHERMAL ENZYMATIC INVITRO NUCLEIC-ACID AMPLIFICATION OPTIMIZED FOR THE DIAGNOSIS OF HIV-1 INFECTION [J].
KIEVITS, T ;
VANGEMEN, B ;
VANSTRIJP, D ;
SCHUKKINK, R ;
DIRCKS, M ;
ADRIAANSE, H ;
MALEK, L ;
SOOKNANAN, R ;
LENS, P .
JOURNAL OF VIROLOGICAL METHODS, 1991, 35 (03) :273-286
[8]   Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening [J].
Lamarcq, L ;
Deeds, J ;
Ginzinger, D ;
Perry, J ;
Padmanabha, S ;
Smith-McCune, K .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2002, 4 (02) :97-102
[9]   Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].
Muñoz, N ;
Bosch, FX ;
de Sanjosé, S ;
Herrero, R ;
Castellsagué, X ;
Shah, KV ;
Snijders, PJF ;
Meijer, CJLM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :518-527
[10]   Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear [J].
Nobbenhuis, MAE ;
Helmerhorst, TJM ;
van den Brule, AJC ;
Rozendaal, L ;
Voorhorst, FJ ;
Bezemer, PD ;
Verheijen, RHM ;
Meijer, CJLM .
LANCET, 2001, 358 (9295) :1782-1783